Stay updated on Pembrolizumab in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Metastatic NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page now shows revision v3.5.4 instead of v3.5.3, representing a newer version of the record and a metadata refresh rather than a substantive change to the study details.
    Difference
    0.1%
    Check dated 2026-05-15T05:57:42.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page’s UI/build “Revision” marker was updated from v3.5.2 to v3.5.3. This reflects a platform version change rather than an update to the trial details.
    Difference
    0.1%
    Check dated 2026-04-23T21:56:24.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.5.2 is now displayed, replacing Revision: v3.5.0. This appears to be an internal version update with no changes to the study content.
    Difference
    0.1%
    Check dated 2026-04-16T18:34:41.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Added revision note v3.5.0 and removed revision note v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T22:27:58.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    Revision updated to v3.4.3; the prior revision v3.4.2 is superseded. This appears to be a metadata update with no changes to the study details.
    Difference
    0.1%
    Check dated 2026-03-11T18:49:23.000Z thumbnail image
  9. Check
    106 days ago
    Change Detected
    Summary
    Addition of Revision: v3.4.2 and deletion of notices about government funding lapse and prior Revision: v3.4.1. These updates are administrative in nature and do not modify study data or core page content.
    Difference
    0.5%
    Check dated 2026-02-11T09:27:05.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Metastatic NSCLC Clinical Trial page.